Vida-Ventures-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ALLO",
  "KYTX",
  "KRON"
]

13F-HR • 2025-03-31

Data Enrichment

100% identified

3 identified0 unidentified

Holdings

Manager:

3 positions • $13.6M total value

Manager:

Search and click to pin securities to the top

Sort by:

Kyverna Therapeutics, Inc.

Shares:4.5M

Value:$8.7M

% of Portfolio:64.0% ($8.7M/$13.6M)

Allogene Therapeutics, Inc.

Shares:1.8M

Value:$2.6M

% of Portfolio:19.3% ($2.6M/$13.6M)

Kronos Bio, Inc.

Shares:2.8M

Value:$2.3M

% of Portfolio:16.7% ($2.3M/$13.6M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Kyverna Therapeutics, Inc.(KYTXcusip501976104)	4.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$8.7M	64.0% ($8.7M/$13.6M)	QoQ -48.39% (-$8.2M) YoY -92.23% (-$103.6M)
Allogene Therapeutics, Inc.(ALLOcusip019770106)	1.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.6M	19.3% ($2.6M/$13.6M)	QoQ -31.45% (-$1.2M) YoY -67.33% (-$5.4M)
Kronos Bio, Inc.(KRONcusip50107A104)	2.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.3M	16.7% ($2.3M/$13.6M)	QoQ -13.15% (-$345.7K) YoY -36.53% (-$1.3M)